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DOI 10.1016/j.stem.2009.10.017The recent application of approaches
used to study somatic stem cells to the
field of cancer biology has provided new
insight into the nature of the cells and
the molecular mechanisms that may be
responsible for initiating or driving tumor
progression. While this advance began
with blood-borne cancers, it has quickly
found applicability and relevance in
solid tissue cancers, in particular one of
the more aggressive of these types of
cancers—the CNS-specific Glioblastoma
Multiforme tumors. This is the most com-
mon adult brain tumor and has a poor
prognosis despite current state-of-the-
art treatments. In solving complex and
difficult problems, a new perspective or
methodological approach is always wel-
come, as it offers a fresh point of view,
which may overcome long standing road
blocks or provide novel solutions. It is
with this in mind that we read the recent
Resource article by Pollard and col-
leagues with great hope and interest
(Pollard et al., 2009).
The article is a collaboration of two
influential laboratories. Implementing a
modification of the original method to
culture neural stem cells (Reynolds and
Weiss, 1992) (addition of laminin as an
attachment factor, Smith laboratory), the
authors undertook a series of experi-
ments to culture primary GBM cells.
These were grown as adherent cultures
on laminin-coated plates rather than
under the more traditional neurosphere,
suspension conditions. While a side-by-
side comparison was not performed, a
number of differences between the two
culture systems are suggested, leading
the authors to conclude that adherent
cultures offer a significant advantage
over sphere cultures, providing for more
refined studies of tumor stem cells.
The view is purported that the neuro-
sphere assay conditions are improved
by the adherent growth conditions, based
on reduced differentiation and apoptosis,
ability to expand a highly enriched cancer
stem cell population, and cell line deriva-466 Cell Stem Cell 5, November 6, 2009 ª2tion of virtually 100% of primary samples.
While these conclusions would clearly be
reason for excitement, we observe that
there is a lack of quantitative data to
support some of these claims and that
some of the data presented in the main
article actually points to the opposite con-
clusions.
(1) Differentiation: The authors argue
that suspension cultures exhibit increased
differentiation, compared to the adherent
growth conditions. This is supported by
micrographs in Figure 2 demonstrating
increased O4-, TuJ-1- immunoreactivity
and increased GFAP- and TuJ1-immu-
nostaining (Figure S1) in the glioma-
derived spheres compared to adherent
cultures. The absence of a quantitative
analysis makes it difficult to discern how
different the two culture conditions might
be with regards to numbers or extent
of differentiation or whether the differ-
ences, if any, are statistically significant.
Of note, the immunofluorescence in Fig-
ure 2 portrays overgrown spheres in
which cultures have been left to expand
beyond the suitable limits for proper prop-
agation, potentially biasing the compar-
ison. This has been discussed in detail
before (Gritti et al., 2001) where we have
detailed how overgrowth results in deple-
tion of the medium, increased apoptosis/
differentiation, and how this can be pre-
vented by subculturing at an appropriate,
early enough stage. The conclusion of
increased differentiation is further ques-
tioned by the data in Figure S1B, where
the authors demonstrate an increase in
the expression of nestin—a protein whose
expression is found in undifferentiated
CNS cells—in the sphere cultures, data
that contradicts the figure title that
states ‘‘Spheres Exhibit Increased Differ-
entiation..’’
(2) Tumor-initiating ability: Pollard et al.
(2009) demonstrate the ability of the
adherent cultures to form tumors, even
when as few as 100 cells are implanted
into immunocompromised mice, and
note that implantation of adherent cells009 Elsevier Inc.is consistent with previously published
data using acutely isolated CD133+
cells. However, while cells derived from
adherent cultures can initiate tumor
formation following grafting, the resulting
tumor formation incidence is, in contrary
to that stated in the manuscript, not con-
sistent with previous published CD133
implant data. Taking data from the Dirk’s
laboratory landmark 2004 Nature paper
(Singh et al., 2004) (Table S3), of the 21
animals that received GBM implants
from four different patients, 0% (0/12) of
the CD133 cells resulted in tumor forma-
tion, while 100% (9/9) of the CD133+ cells
produced tumors (includes four animals
that received 100 CD133+ cells and five
that had been implanted with 1000
CD133+ cells). This is in contrast with the
results of Pollard et al. who report tumor
formation in 15% (2/13) and 39% (5/13)
of the donors who received 100 and
1000 adherent cultured cells, respec-
tively. Hence, the implied conclusion that
GBM cells in adherent cultures are as
tumor forming as that reported for purified
CD133+ cells is not accurate. While the
authors assume the tumorigenicity will
be greater in the adherent cultures as
compared to the suspension cultures,
they do acknowledge that this has not
been demonstrated and that a side-by-
side comparison needs to be undertaken
to support this notion.
(3) Apoptosis: The authors claim that
cultures grown as spheres exhibit
increased apoptosis compared to the
adherent conditions based on a figure
revealing several Tunel-labeled cells
within a sphere compared to a tunel
negative photograph taken of Laminin-
attached cells. This is further confirmed
by a flow plot demonstrating increased
PI and AnnexinV staining on live cells in
sphere cultures verses adherent growth
conditions. However, while these data
suggest that increased apoptosis is
occurring in the sphere cultures—due to
their overgrowth—the absence of any
cell counts from the Tunel staining, and
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of the PI and AnnexinV data, diminishes
the validity of the conclusion that the
tumor neurosphere assay results in ele-
vated cell death.
(4) Pure tumor stem cell population: The
use of an adhesive substrate to expand
somatic neural stem cell progeny was
originally reported by Scheffler et al.
(2005) and subsequently further devel-
oped by the Smith laboratory. The addi-
tion of laminin alters the growth conditions
of the proliferating precursors where they
demonstrate a relatively homogeneous
expression of undifferentiated neural
markers. Applying this method to expan-
sion of glioma tumor stem cell cultures
by Pollard et al. resulted in a similar lack
of expression of differentiation markers
and an apparent homogeneous expres-
sion of proteins found in undifferentiated
cells (as noted above, the absence of
quantitative data makes it difficult to
assess this statement). Based on non-
quantified expression of cellular markers
and the ability of a relatively small popula-
tion of adherent expanded tumor cells to
initiate tumor formation in a minority of
the implanted animals (15% and 39%
when 100 or 1000 cells were implanted,
respectively), the authors conclude that
using the adherent growth conditions
results in the expansion of a pure popula-
tion of cancer stem cells. However, lack of
differentiation markers in a given cell is in
no way equated to being a stem cell.
Without evidence demonstrating that
each cell cultured under these conditions
(or the progeny of these cells) is able to
exhibit cancer stem cell characteristics
(i.e., extensive self-renewal, generation
large number of progeny, multilineage
differentiation capability, and tumor
formation), the assessment that the
culture contains a homogeneous cancer
stem cell population is unfounded. In the
absence of clonal data on a significant
number of cells, we are left with unan-swered questions as to the identity, fate,
and potential of the professed homoge-
neous population.
It is possible though to address this
issue in the absence of quantitative data
by the following thought experiment. If
adhered cultures contained significantly
more cancer stemcells than neurospheres
(as close to 100% as suggested), their
expansion rate would greatly exceed that
of neurospheres by several orders of
magnitude. However, this does not appear
to be the case, as the authors state that
they are able to subculture their cells
22 times in one year. This represents a
slower growth rate (and presumably
a lower cancer stem cell content) com-
pared to neurospheres, where we typically
passage the cells in our hands greater than
50 times in a year (with some lines being
over 150 passages). A similar consider-
ation goes for the efficiency in establishing
cancerstemcell lines,asdiscussedbelow.
(5) Efficiency in culture establishment.
The standard efficiency for cell line estab-
lishment with the neuropshere method
approaches 100%, as shown in our labo-
ratories and others in a survey of well over
150 surgery specimens. This is unlike the
low efficiency—2 out of 6 (see page
569)—that the authors report for their
laboratories. This confirms that, while we
do not know why cell line establishment
is low in this report, there is no need for
an adhesion method to be applied to
accomplish complete total efficiency in
cell line establishment. Quite to the con-
trary, the authors report that, in at least
two cases, the establishment of their cell
lines occurred through the formation, har-
vesting, and subculturing of actual neuro-
spheres, rather than through cultures
expanding in adhesion: that this is actually
due to an excess of debris remains
unclear. This weakens the notion that
the adherent system is a more effective
method to isolate cancer stem cells from
brain tumors.Cell Stem Cell 5While we, and certainly others in the
tumor stem cell research area, look
forward to incorporating new methods
into our repertoire of tools to dissect
and understand the complex biology
of cancer cells, the validity of new
approaches and their advancement over
existing techniques need to be based on
quantitative data, not qualitative assess-
ments that support conclusions resulting
from suppositional interpretations of
experiments. The conclusions drawn
that the adherent culture system repre-
sents a more efficient procedure are
premature. This is not to say that applica-
tion of the neurosphere assaymodified by
the addition of laminin does not represent
an alternative technique for cancer stem
cell work; however, this will have to await
the addition of more definitive quantitative
data.
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